Literature DB >> 26280824

Proposal of Venous Drainage-Based Classification System for Carotid Cavernous Fistulae With Validity Assessment in a Multicenter Cohort.

Ajith J Thomas1, Michelle Chua, Matthew Fusco, Christopher S Ogilvy, R Shane Tubbs, Mark R Harrigan, Christoph J Griessenauer.   

Abstract

BACKGROUND: Carotid cavernous fistulae (CCFs) are most commonly classified based on arterial supply. Symptomatology and treatment approach, however, are largely influenced by venous drainage.
OBJECTIVE: To propose an updated classification system using venous drainage.
METHODS: CCFs with posterior/inferior drainage only, posterior/inferior and anterior drainage, anterior drainage only, and retrograde drainage into cortical veins with/without other drainage channels were designated as types 1, 2, 3, and 4, respectively. CCFs involving a direct connection between the internal carotid artery and cavernous sinus were designated as type 5. This system was retrospectively applied to 29 CCF patients.
RESULTS: Our proposed classification was significantly associated with symptomatology (P < .001). Type 2 was significantly associated with coexisting ocular/orbital and cavernous symptoms only (P < .001), type 3 with ocular/orbital symptoms only (P < .01), and type 4 demonstrated cortical symptoms with/without ocular/orbital and cavernous symptoms (P < .01), respectively. There was a significant association of our classification system with the endovascular treatment approach (P < .001). Types 1 and 2 were significantly associated with endovascular treatment through the inferior petrosal sinus (P < .01). Type 3 was significantly associated with endovascular treatment through the ophthalmic vein (P < .01) and type 5 with transarterial approach (P < .01), respectively. Types 2 (27.6%) and 3 (34.5%) were most prevalent in this series, whereas type 1 was rare (6.9%), suggesting that some degree of thrombosis is present, with implications for spontaneous resolution. Type 2 CCFs demonstrated a trend toward partial resolution after endovascular treatment (P = .07).
CONCLUSION: Our proposed classification system is easily applicable in clinical practice and demonstrates correlation with symptomatology, treatment approach, and outcome.

Entities:  

Mesh:

Year:  2015        PMID: 26280824     DOI: 10.1227/NEU.0000000000000829

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  6 in total

Review 1.  Traumatic arteriovenous fistula between the extracranial middle meningeal artery and the pterygoid plexus: A case report and literature review.

Authors:  Jinlu Yu; Yunbao Guo; Zhongxue Wu; Kan Xu
Journal:  Interv Neuroradiol       Date:  2016-10-27       Impact factor: 1.610

2.  Percutaneous Ultrasound-Guided Access to the Superior Ophthalmic Vein for Embolization of a Cavernous Sinus Dural Arteriovenous Fistula.

Authors:  Pham Hong Duc; Nguyen Thi Thai Hoa; Huynh Quang Huy; Anh Quoc Nguyen
Journal:  Cureus       Date:  2020-05-11

3.  Endovascular management of cavernous sinus dural arteriovenous fistulas: Overall review and considerations.

Authors:  Jong Min Lee; Eun Suk Park; Soon Chan Kwon
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2021-12-17

4.  Gamma Knife Radiosurgery for Indirect Dural Carotid-Cavernous Fistula: Long-Term Ophthalmological Outcome.

Authors:  Chiung-Chyi Shen; Yuang-Seng Tsuei; Meng-Yin Yang; Weir-Chiang You; Ming-His Sun; Meei-Ling Sheu; Liang-Yi Pan; Jason Sheehan; Hung-Chuan Pan
Journal:  Life (Basel)       Date:  2022-08-01

Review 5.  Endovascular treatment of the cavernous sinus dural arteriovenous fistula: current status and considerations.

Authors:  Kun Hou; Guichen Li; Tengfei Luan; Kan Xu; Jinlu Yu
Journal:  Int J Med Sci       Date:  2020-05-01       Impact factor: 3.738

6.  Expanding Indications for Flow Diverters: Distal Aneurysms, Bifurcation Aneurysms, Small Aneurysms, Previously Coiled Aneurysms and Clipped Aneurysms, and Carotid Cavernous Fistulas.

Authors:  Nicola Limbucci; Giuseppe Leone; Leonardo Renieri; Sergio Nappini; Federico Cagnazzo; Antonio Laiso; Mario Muto; Salvatore Mangiafico
Journal:  Neurosurgery       Date:  2020-01-01       Impact factor: 4.654

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.